Back to publications

2025 PUBLICATIONS:

  • Bhushan A, Thompson PJ. Inflammatory β-Cell Stress and Immune Surveillance in Type 1 Diabetes. Cold Spring Harbor Perspectives in Medicine. 2025 Jul 1;15(7):a041605.

  • Wang Y, Apostolopoulou H, Sun IH, Bains A, Gibbs D, Huang S, Alliston T, Maker A, Tlsty T, Ntranos V, Gardner JM, Bhushan A. Blocking Osteoprotegerin Reprograms Cancer Associated Fibroblast to Promotes Immune Infiltration into the Tumor Microenvironment. bioRxiv. 2025 Jul 7:2025-07.

  • Parent AV, Agarwal A, Alvarez-Dominguez JR, Arrojo e Drigo R, Atkinson MA, Brehm MA, Ferreira LM, Kaestner KH, Kravets V, Niland JC, O’Meally D. Closing the gap between vision and victory in type 1 diabetes: the NIDDK Human Islet Research Network (HIRN) initiative. Diabetes. 2025 Jul 1;74(7):1057-67.

  • Chen P, Chang B, Creasey OA, Sneddon JB, Liu Y. Geometric Framework for 3D Cell Segmentation Correction. arXiv e-prints. 2025 Feb:arXiv-2502.

  • Castro-Gutierrez R, Tang Q. Face off: Stem cell therapy versus the immune system. Cell Stem Cell. 2025 Sep 4;32(9):1318-20.

  • Muller YD, Ho P, Bluestone JA, Tang Q. Rebalancing the Immune System to Treat Type 1 Diabetes. Cold Spring Harbor perspectives in medicine. 2025 Aug 1;15(8):a041599.

  • Tang Q. Acquired immune tolerance 2.0. American Journal of Transplantation. 2025 May 1;25(5):890-2.

  • Porret R, Alcaraz-Serna A, Peter B, Bernier-Latmani J, Cecchin R, Alfageme-Abello O, Ermellino L, Hafezi M, Pace E, du Pré MF, Lana E, Golshayan D, Velin D, Eyquem J, Tang Q, Petrova TV, Coukos G, Irving M, Pot C, Pantaleo G, Sollid LM, Muller YD. T cell receptor precision editing of regulatory T cells for celiac disease. Science translational medicine. 2025 Mar 19;17(790):eadr8941.

  • Indart A, Lyu H, Nguyen V, Rosenthal W, Jang S, Chen Y, Jude K, Su L, Garcia KC, Bluestone JA, Tang Q. Receptor-tethered orthogonal IL-2 enhances regulatory T cell therapy. bioRxiv. 2025:2025-07.

  • Bhagchandani P, Ramos SA, Rodriguez B, Gu X, Patha S, Zhou Y, Moon Y, Nourin N, Chang CA, Poyser J, Velasco BJ, Zhao, W, Kwon H-S, Rodriguez R, Burgos D, Miranda MA, Meyer E, Shizuru J, Kim SK. 2025. Curing autoimmune diabetes with islet and hematopoietic cell transplantation after CD117 antibody-based conditioning. J. Clin Invest. in revision.

  •  Ramos SA, Bhagchandani P, Burgos DM, Gu X, Rodriguez R, Nourin N, Neukam M, Pathak S, Shizuru JA, Kim SK. 2025. Improved conditioning for hematopoietic chimerism induces islet tolerance to cure diabetes. JCI Insight. in revision.

  • Hang Y, Miranda MA, Yan Z, Zhao W, Kim SK. Isolation of live human δ cells for genetic and functional analysis. Mol Metab. 2025 Jun 11:102188. doi: 10.1016/j.molmet.2025.102188. Epub ahead of print. PMID: 40514008.

  • Kattner N, Hang Y, Krentz NAJ, Russell LA, Palmer M, Flaxman C, Plett N, Coulthard R, Al-Selwi Y, Dyson N, Honkanen-Scott M, Kim SK, Tiniakos D, Klöppel G, Richardson SJ, Shaw JAM. Identification of a vimentin-expressing α-cell phenotype in CF and normal pancreas. J Endocrinol. 2025 Feb 17;264(3):e240190. doi: 10.1530/JOE-24-0190. PMID: 39836539; PMCID: PMC11850051.

  • Wu X, Chen PI, Whitener RL, MacDougall MS, Coykendall VMN, Yan H, Kim YB, Harper W, Pathak S, Iliopoulou BP, Hestor A, Saunders DC, Spears E, Sévigny J, Maahs DM, Basina M, Sharp SA, Gloyn AL, Powers AC, Kim SK, Jensen KP, Meyer EH. CD39 delineates chimeric antigen receptor regulatory T cell subsets with distinct cytotoxic & regulatory functions against human islets. 2024. Front Immunol. 15:1415102. doi: 10.3389/fimmu.2024.1415102. PMID: 39007132.

  • Chiu DK, Zhang X, Cheng BY, Liu Q, Hayashi K, Yu B, Lee R, Zhang C, An X, Rajadas J, Reticker-Flynn NE, Rankin EB, Engleman EG. Tumor-derived erythropoietin acts as an immunosuppressive switch in cancer immunity. Science. 2025 Apr 25;388(6745):eadr3026. doi: 10.1126/science.adr3026. Epub 2025 Apr 25. PMID: 40273234; PMCID: PMC12110762.

  • Agarwal R, Bertaina A, Soco C, Long-Boyle JR, Saini G, Kunte N, Hiroshima L, Chan YY, Willner H, Krampf MR, Nofal R, Barbarito G, Sen S, Van Hentenryck M, Walck E, Scheck A, Perriman RJ, Bouge A, Istomina E, Din HN, Klinger EF, Cheng JC, Wlodarski MW, Boelens JJ, Shizuru JA, Pang WW, Weinberg K, Parkman R, Roncarolo MG, Porteus M, Czechowicz A. Irradiation- and busulfan-free stem cell transplantation in Fanconi anemia using an anti-CD117 antibody: a phase 1b trial. Nat Med. 2025 Jul 22. doi: 10.1038/s41591-025-03817-1. Online ahead of print. PMID: 40696207

  • Zheng SL, Fowler JL, Chen JY, Li C, Lin E, Nguyen AT, Chen A, Daley GQ, Ang LT, Loh KM (2025). Protocol for the generation of HLF+ HOXA+ human hematopoietic progenitor cells from pluripotent stem cells. STAR Protocols 6: 103592.